{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:27:37Z","timestamp":1795156057515,"version":"4.10.3"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR205"],"award-info":[{"award-number":["TRR205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SPP2306"],"award-info":[{"award-number":["SPP2306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LI 2107\/10-1"],"award-info":[{"award-number":["LI 2107\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IRTG2251"],"award-info":[{"award-number":["IRTG2251"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ferroptosis has attracted attention throughout the last decade because of its tremendous clinical importance. Here, we review the rapidly growing body of literature on how inhibition of ferroptosis may be harnessed for the treatment of common diseases, and we focus on metabolic and cardiovascular unmet medical needs. We introduce four classes of preclinically established ferroptosis inhibitors (ferrostatins) such as iron chelators, radical trapping agents that function in the cytoplasmic compartment, lipophilic radical trapping antioxidants and ninjurin-1 (NINJ1) specific monoclonal antibodies. In contrast to ferroptosis inducers that cause serious untoward effects such as acute kidney tubular necrosis, the side effect profile of ferrostatins appears to be limited. We also consider ferroptosis as a potential side effect itself when several advanced therapies harnessing small-interfering RNA (siRNA)-based treatment approaches are tested. Importantly, clinical trial design is impeded by the lack of an appropriate biomarker for ferroptosis detection in serum samples or tissue biopsies. However, we discuss favorable clinical scenarios suited for the design of anti-ferroptosis clinical trials to test such first-in-class compounds. We conclude that targeting ferroptosis exhibits outstanding treatment options for metabolic and cardiovascular diseases, but we have only begun to translate this knowledge into clinically relevant applications.<\/jats:p>","DOI":"10.1038\/s41418-024-01350-1","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T21:01:34Z","timestamp":1722114094000},"page":"1104-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-2055","authenticated-orcid":false,"given":"Francesca","family":"Maremonti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-1413","authenticated-orcid":false,"given":"Wulf","family":"Tonnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-1453","authenticated-orcid":false,"given":"Shubhangi","family":"Gavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-7225","authenticated-orcid":false,"given":"Mauro","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-9725","authenticated-orcid":false,"given":"Andreas","family":"Linkermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, et al. Apoptotic cell death in disease\u2014current understanding of the NCCD 2023. Cell Death Differ. 2023;30:1097\u2013154.","journal-title":"Cell Death Differ"},{"key":"1350_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Green DR. Necroptosis. N Engl J Med. 2014;370:455\u201365.","journal-title":"N Engl J Med"},{"key":"1350_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell"},{"key":"1350_CR4","doi-asserted-by":"crossref","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","DOI":"10.1038\/s41580-024-00703-5"},{"key":"1350_CR5","doi-asserted-by":"crossref","unstructured":"Veeckmans G, Van San E, Vanden Berghe T. A guide to ferroptosis, the biological rust of cellular membranes. FEBS J. 2023;291:2767\u201383.","DOI":"10.1111\/febs.16993"},{"key":"1350_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2014.137","volume":"22","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015;22:58\u201373.","journal-title":"Cell Death Differ"},{"key":"1350_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41586-023-05991-z","volume":"618","author":"M Degen","year":"2023","unstructured":"Degen M, Santos JC, Pluhackova K, Cebrero G, Ramos S, Jankevicius G, et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature. 2023;618:1065\u201371.","journal-title":"Nature"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-023-06191-5","volume":"618","author":"N Kayagaki","year":"2023","unstructured":"Kayagaki N, Stowe IB, Alegre K, Deshpande I, Wu S, Lin Z, et al. Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury. Nature. 2023;618:1072\u20137.","journal-title":"Nature"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s44318-024-00055-y","volume":"43","author":"S Ramos","year":"2024","unstructured":"Ramos S, Hartenian E, Santos JC, Walch P, Broz P. NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis. EMBO J. 2024;43:1164\u201386.","journal-title":"EMBO J"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"1350_CR12","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1111\/ajt.13963","volume":"16","author":"WG Land","year":"2016","unstructured":"Land WG, Agostinis P, Gasser S, Garg AD, Linkermann A. Transplantation and damage-associated molecular patterns (DAMPs). Am J Transplant. 2016;16:3338\u201361.","journal-title":"Am J Transplant"},{"key":"1350_CR13","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1111\/ajt.14012","volume":"16","author":"WG Land","year":"2016","unstructured":"Land WG, Agostinis P, Gasser S, Garg AD, Linkermann A. DAMP-induced allograft and tumor rejection: the circle is closing. Am J Transplant. 2016;16:3322\u201337.","journal-title":"Am J Transplant"},{"key":"1350_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00041.2016","volume":"98","author":"M Sarhan","year":"2018","unstructured":"Sarhan M, Land WG, Tonnus W, Hugo CP, Linkermann A. Origin and consequences of necroinflammation. Physiol Rev. 2018;98:727\u201380.","journal-title":"Physiol Rev"},{"key":"1350_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000490807","volume":"140","author":"A von Massenhausen","year":"2018","unstructured":"von Massenhausen A, Tonnus W, Linkermann A. Cell death pathways drive necroinflammation during acute kidney injury. Nephron. 2018;140:144\u20137.","journal-title":"Nephron"},{"key":"1350_CR16","first-page":"333","volume":"18","author":"C Greenhill","year":"2022","unstructured":"Greenhill C. Dexamethasone in patients with diabetes mellitus. Nat Rev Endocrinol. 2022;18:333.","journal-title":"Nat Rev Endocrinol"},{"key":"1350_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl8920","volume":"8","author":"A von M\u00e4ssenhausen","year":"2022","unstructured":"von M\u00e4ssenhausen A, Zamora Gonzalez N, Maremonti F, Belavgeni A, Tonnus W, Meyer C, et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci Adv. 2022;8:eabl8920.","journal-title":"Sci Adv"},{"key":"1350_CR18","doi-asserted-by":"crossref","unstructured":"Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401\u201310.","DOI":"10.1038\/s41586-023-06878-9"},{"key":"1350_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","volume":"626","author":"Y Li","year":"2024","unstructured":"Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626:411\u20138.","journal-title":"Nature"},{"key":"1350_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41574-021-00499-w","volume":"17","author":"W Tonnus","year":"2021","unstructured":"Tonnus W, Belavgeni A, Beuschlein F, Eisenhofer G, Fassnacht M, Kroiss M, et al. The role of regulated necrosis in endocrine diseases. Nat Rev Endocrinol. 2021;17:497\u2013510.","journal-title":"Nat Rev Endocrinol"},{"key":"1350_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen SL, R\u00f8rth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7:776\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1350_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","volume":"19","author":"H Bay\u0131r","year":"2023","unstructured":"Bay\u0131r H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023;19:315\u201336.","journal-title":"Nat Rev Nephrol"},{"key":"1350_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.123.323715","volume":"133","author":"E Bertero","year":"2023","unstructured":"Bertero E, Maack C. Ins and outs of glutathione in cardiac ischemia\/reperfusion injury. Circ Res. 2023;133:877\u20139.","journal-title":"Circ Res"},{"key":"1350_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1573403X18666220413121730","volume":"18","author":"LN Maslov","year":"2022","unstructured":"Maslov LN, Popov SV, Mukhomedzyanov AV, Naryzhnaya NV, Voronkov NS, Ryabov VV, et al. Reperfusion cardiac injury: receptors and the signaling mechanisms. Curr Cardiol Rev. 2022;18:63\u201379.","journal-title":"Curr Cardiol Rev"},{"key":"1350_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.surg.2024.02.001","volume":"175","author":"ZP Rokop","year":"2024","unstructured":"Rokop ZP, Zhang W, Ghosh N, Biswas N, Das A, Lin J, et al. Exacerbated ischemia-reperfusion injury in fatty livers is mediated by lipid peroxidation stress and ferroptosis. Surgery. 2024;175:1539\u201346.","journal-title":"Surgery"},{"key":"1350_CR26","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/ajt.15773","volume":"20","author":"N Yamada","year":"2020","unstructured":"Yamada N, Karasawa T, Wakiya T, Sadatomo A, Ito H, Kamata R, et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: potential role of ferroptosis. Am J Transplant. 2020;20:1606\u201318.","journal-title":"Am J Transplant"},{"key":"1350_CR27","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA 2014;111:16836\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1350_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24712-6","volume":"12","author":"W Tonnus","year":"2021","unstructured":"Tonnus W, Meyer C, Steinebach C, Belavgeni A, von M\u00e4ssenhausen A, Gonzalez NZ, et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat Commun. 2021;12:4402.","journal-title":"Nat Commun"},{"key":"1350_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15:135\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1350_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.plantsci.2018.05.001","volume":"279","author":"C Mata-P\u00e9rez","year":"2019","unstructured":"Mata-P\u00e9rez C, Spoel SH. Thioredoxin-mediated redox signalling in plant immunity. Plant Sci. 2019;279:27\u201333.","journal-title":"Plant Sci"},{"key":"1350_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/2589977515666230214101808","volume":"15","author":"A Kar","year":"2023","unstructured":"Kar A, Paramasivam B, Jayakumar D, Swaroop AK, Jubie S. Thioredoxin interacting protein inhibitors in diabetes mellitus: a critical review. Curr Drug Res Rev. 2023;15:228\u201340.","journal-title":"Curr Drug Res Rev"},{"key":"1350_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/ars.2021.0038","volume":"36","author":"H Masutani","year":"2022","unstructured":"Masutani H. Thioredoxin-interacting protein in cancer and diabetes. Antioxid Redox Signal. 2022;36:1001\u201322.","journal-title":"Antioxid Redox Signal"},{"key":"1350_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15:1137\u201347.","journal-title":"Nat Chem Biol"},{"key":"1350_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"1350_CR35","doi-asserted-by":"crossref","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2017;172:409\u2013422.e21.","DOI":"10.1016\/j.cell.2017.11.048"},{"key":"1350_CR36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks J, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"1350_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"1350_CR38","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748\u201364.e22.","journal-title":"Cell"},{"key":"1350_CR39","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","volume":"33","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Cai R, Volchuk A, Steinberg BE, Saito Y, Matsuzawa A, et al. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33:1282\u201394.e5.","journal-title":"Curr Biol"},{"key":"1350_CR40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.cell.2024.03.008","volume":"187","author":"L David","year":"2024","unstructured":"David L, Borges JP, Hollingsworth LR, Volchuk A, Jansen I, Garlick E, et al. NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks. Cell. 2024;187:2224\u201335.e16.","journal-title":"Cell"},{"key":"1350_CR41","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","volume":"177","author":"I Alim","year":"2019","unstructured":"Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177:1262\u201379.e25.","journal-title":"Cell"},{"key":"1350_CR42","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1093\/eurheartj\/ehac463","volume":"43","author":"AM Shah","year":"2022","unstructured":"Shah AM, Giacca M. Small non-coding RNA therapeutics for cardiovascular disease. Eur Heart J. 2022;43:4548\u201361.","journal-title":"Eur Heart J"},{"key":"1350_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk7329","volume":"10","author":"A von M\u00e4ssenhausen","year":"2024","unstructured":"von M\u00e4ssenhausen A, Schlecht MN, Beer K, Maremonti F, Tonnus W, Belavgeni A, et al. Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis. Sci Adv. 2024;10:eadk7329.","journal-title":"Sci Adv"},{"key":"1350_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"1350_CR45","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1350_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/iub.1616","volume":"69","author":"S Doll","year":"2017","unstructured":"Doll S, Conrad M. Iron and ferroptosis: a still ill-defined liaison. IUBMB Life. 2017;69:423\u201334.","journal-title":"IUBMB Life"},{"key":"1350_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148383","volume":"1812","author":"H Jia","year":"2023","unstructured":"Jia H, Liu X, Cao Y, Niu H, Lan Z, Li R, et al. Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. Brain Res. 2023;1812:148383.","journal-title":"Brain Res"},{"key":"1350_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0091270011418657","volume":"52","author":"CM Fraga","year":"2012","unstructured":"Fraga CM, Tomasi CD, Biff D, Topanotti MF, Felisberto F, Vuolo F, et al. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial. J Clin Pharm. 2012;52:1365\u201372.","journal-title":"J Clin Pharm"},{"key":"1350_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13054-016-1504-1","volume":"20","author":"CM Fraga","year":"2016","unstructured":"Fraga CM, Tomasi CD, Damasio DC, Vuolo F, Ritter C, Dal-Pizzol F. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial. Crit Care. 2016;20:331.","journal-title":"Crit Care"},{"key":"1350_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41589-022-01145-w","volume":"19","author":"U Barayeu","year":"2023","unstructured":"Barayeu U, Schilling D, Eid M, Xavier da Silva TN, Schlicker L, Mitreska N, et al. Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals. Nat Chem Biol. 2023;19:28\u201337.","journal-title":"Nat Chem Biol"},{"key":"1350_CR51","doi-asserted-by":"publisher","first-page":"e64806","DOI":"10.7554\/eLife.64806","volume":"10","author":"L Zeitler","year":"2021","unstructured":"Zeitler L, Fiore A, Meyer C, Russier M, Zanella G, Suppmann S, et al. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism. eLife. 2021;10:e64806.","journal-title":"eLife"},{"key":"1350_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104827","volume":"299","author":"L Zeitler","year":"2023","unstructured":"Zeitler L, Murray PJ. IL4i1 and IDO1: oxidases that control a tryptophan metabolic nexus in cancer. J Biol Chem. 2023;299:104827.","journal-title":"J Biol Chem"},{"key":"1350_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28718-6","volume":"13","author":"S Van Coillie","year":"2022","unstructured":"Van Coillie S, Van San E, Goetschalckx I, Wiernicki B, Mukhopadhyay B, Tonnus W, et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat Commun. 2022;13:1046.","journal-title":"Nat Commun"},{"key":"1350_CR54","doi-asserted-by":"crossref","unstructured":"Mishima E, Sato E, Ito J, Yamada KI, Suzuki C, Oikawa Y, et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J Am Soc Nephrol. 2019;31:280\u201396.","DOI":"10.1681\/ASN.2019060570"},{"key":"1350_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben R, James LP, et al. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nat Commun. 2023;14:6182.","journal-title":"Nat Commun"},{"key":"1350_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"1350_CR57","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608:778\u201383.","journal-title":"Nature"},{"key":"1350_CR58","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675\u201385.","journal-title":"N Engl J Med"},{"key":"1350_CR59","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajt.2022.12.015","volume":"23","author":"C Eelderink","year":"2023","unstructured":"Eelderink C, Kremer D, Riphagen IJ, Knobbe TJ, Schurgers LJ, Pasch A, et al. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: a double-blind, randomized, placebo-controlled clinical trial. Am J Transplant. 2023;23:520\u201330.","journal-title":"Am J Transplant"},{"key":"1350_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","volume":"84","author":"Y Ai","year":"2024","unstructured":"Ai Y, Meng Y, Yan B, Zhou Q, Wang X. The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell. 2024;84:170\u20139.","journal-title":"Mol Cell"},{"key":"1350_CR61","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.1996.384","volume":"50","author":"K Sogabe","year":"1996","unstructured":"Sogabe K, Roeser NF, Venkatachalam MA, Weinberg JM. Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int. 1996;50:845\u201354.","journal-title":"Kidney Int"},{"key":"1350_CR62","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ki.1997.313","volume":"52","author":"JM Weinberg","year":"1997","unstructured":"Weinberg JM, Roeser NF, Davis JA, Venkatachalam MA. Glycine-protected, hypoxic, proximal tubules develop severely compromised energetic function. Kidney Int. 1997;52:140\u201351.","journal-title":"Kidney Int"},{"key":"1350_CR63","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136:4551\u20136.","journal-title":"J Am Chem Soc"},{"key":"1350_CR64","doi-asserted-by":"publisher","first-page":"e78609","DOI":"10.7554\/eLife.78609","volume":"11","author":"JP Borges","year":"2022","unstructured":"Borges JP, S\u00e6tra RSR, Volchuk A, Bugge M, Devant P, Sporsheim B, et al. Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. eLife. 2022;11:e78609.","journal-title":"eLife"},{"key":"1350_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm0142","volume":"8","author":"A Lau","year":"2022","unstructured":"Lau A, Rahn JJ, Chappellaz M, Chung H, Benediktsson H, Bihan D, et al. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Sci Adv. 2022;8:eabm0142.","journal-title":"Sci Adv"},{"key":"1350_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174178","volume":"905","author":"W Alshaer","year":"2021","unstructured":"Alshaer W, Zureigat H, Al Karaki A, Al-Kadash A, Gharaibeh L, Hatmal MM, et al. siRNA: mechanism of action, challenges, and therapeutic approaches. Eur J Pharmacol. 2021;905:174178.","journal-title":"Eur J Pharmacol"},{"key":"1350_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coviro.2015.04.004","volume":"12","author":"B Wu","year":"2015","unstructured":"Wu B, Hur S. How RIG-I like receptors activate MAVS. Curr Opin Virol. 2015;12:91\u20138.","journal-title":"Curr Opin Virol"},{"key":"1350_CR68","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2023.10.011","volume":"31","author":"J Rodencal","year":"2024","unstructured":"Rodencal J, Kim N, He A, Li VL, Lange M, He J, et al. Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol. 2024;31:234\u201348.e13.","journal-title":"Cell Chem Biol"},{"key":"1350_CR69","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cell.2014.03.032","volume":"157","author":"BN Puente","year":"2014","unstructured":"Puente BN, Kimura W, Muralidhar SA, Moon J, Amatruda JF, Phelps KL, et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell. 2014;157:565\u201379.","journal-title":"Cell"},{"key":"1350_CR70","doi-asserted-by":"publisher","first-page":"11536","DOI":"10.1021\/jacs.2c03973","volume":"144","author":"M Antoszczak","year":"2022","unstructured":"Antoszczak M, M\u00fcller S, Ca\u00f1eque T, Colombeau L, Dusetti N, Santofimia-Casta\u00f1o P, et al. Iron-sensitive prodrugs that trigger active ferroptosis in drug-tolerant pancreatic cancer cells. J Am Chem Soc. 2022;144:11536\u201345.","journal-title":"J Am Chem Soc"},{"key":"1350_CR71","doi-asserted-by":"crossref","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","DOI":"10.1038\/nature23007"},{"key":"1350_CR72","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340.","journal-title":"Mol Cell"},{"key":"1350_CR73","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99:1765\u2013817.","journal-title":"Physiol Rev"},{"key":"1350_CR74","doi-asserted-by":"crossref","unstructured":"Li W, Feng G, Gauthier JM, Lokshina I, Higashikubo R, Evans S, et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 2019;129:2293\u20132304.","DOI":"10.1172\/JCI126428"},{"key":"1350_CR75","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circ Res. 2020;127:486\u2013501.","journal-title":"Circ Res"},{"key":"1350_CR76","doi-asserted-by":"crossref","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci. 2019;116:2672\u201380.","DOI":"10.1073\/pnas.1821022116"},{"key":"1350_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44228-5","volume":"14","author":"LK Chu","year":"2023","unstructured":"Chu LK, Cao X, Wan L, Diao Q, Zhu Y, Kan Y, et al. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury. Nat Commun. 2023;14:8393.","journal-title":"Nat Commun"},{"key":"1350_CR78","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1074\/jbc.RA119.010949","volume":"294","author":"L Su","year":"2019","unstructured":"Su L, Jiang X, Yang C, Zhang J, Chen B, Li Y, et al. Pannexin 1 mediates ferroptosis that contributes to renal ischemia\/reperfusion injury. J Biol Chem. 2019;294:19395\u2013404.","journal-title":"J Biol Chem"},{"key":"1350_CR79","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41419-020-02871-6","volume":"11","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Wu J, Xu H, Zhou C, Han B, Zhu H, et al. XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury. Cell Death Dis. 2020;11:629.","journal-title":"Cell Death Dis"},{"key":"1350_CR80","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41419-022-05518-w","volume":"13","author":"J Guo","year":"2022","unstructured":"Guo J, Song Z, Yu J, Li C, Jin C, Duan W, et al. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia\/reperfusion injury via suppressing GPX4-mediated ferroptosis. Cell Death Dis. 2022;13:1072.","journal-title":"Cell Death Dis"},{"key":"1350_CR81","doi-asserted-by":"publisher","first-page":"RP89045","DOI":"10.7554\/eLife.89045.4","volume":"12","author":"F Wang","year":"2024","unstructured":"Wang F, Liu X, Huang F, Zhou Y, Wang X, Song Z, et al. Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis. eLife. 2024;12:RP89045.","journal-title":"eLife"},{"key":"1350_CR82","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41418-022-00957-6","volume":"29","author":"Y Wu","year":"2022","unstructured":"Wu Y, Jiao H, Yue Y, He K, Jin Y, Zhang J, et al. Ubiquitin ligase E3 HUWE1\/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ. 2022;29:1705\u201318.","journal-title":"Cell Death Differ"},{"key":"1350_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46386-6","volume":"15","author":"N Yamada","year":"2024","unstructured":"Yamada N, Karasawa T, Ito J, Yamamuro D, Morimoto K, Nakamura T, et al. Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis. Nat Commun. 2024;15:2195.","journal-title":"Nat Commun"},{"key":"1350_CR84","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-023-06135-x","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Zhao L, Li Y, Dang M, Lu J, Lu Z, et al. PPM1K mediates metabolic disorder of branched-chain amino acid and regulates cerebral ischemia-reperfusion injury by activating ferroptosis in neurons. Cell Death Dis. 2023;14:634.","journal-title":"Cell Death Dis"},{"key":"1350_CR85","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/acschemneuro.3c00374","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F, Ma M, Yang J, Shi X, Wang J, Xu Z. Neuroprotective effects of activin A against cerebral ischemia\/reperfusion injury in mice by enhancing Nrf2 expression to attenuate neuronal ferroptosis. ACS Chem Neurosci. 2023;14:2818\u201326.","journal-title":"ACS Chem Neurosci"},{"key":"1350_CR86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10571-022-01196-6","volume":"43","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li K, Zhao Y, Zhou L, Liu Y, Zhao J. Role of ferroptosis in stroke. Cell Mol Neurobiol. 2023;43:205\u201322.","journal-title":"Cell Mol Neurobiol"},{"key":"1350_CR87","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/ejn.16035","volume":"58","author":"T Zhang","year":"2023","unstructured":"Zhang T, Yang M, Ma C, Wei X, Zhang Z. BACH1 encourages ferroptosis by activating KDM4C-mediated COX2 demethylation after cerebral ischemia-reperfusion injury. Eur J Neurosci. 2023;58:2194\u2013214.","journal-title":"Eur J Neurosci"},{"key":"1350_CR88","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X, et al. Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation. 2023;147:1444\u201360.","journal-title":"Circulation"},{"key":"1350_CR89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10495-022-01785-2","volume":"28","author":"X Han","year":"2023","unstructured":"Han X, Zhang J, Liu J, Wang H, Du F, Zeng X, et al. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries. Apoptosis. 2023;28:108\u201323.","journal-title":"Apoptosis"},{"key":"1350_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.799499","volume":"9","author":"JY Li","year":"2021","unstructured":"Li JY, Liu SQ, Yao RQ, Tian YP, Yao YM. A novel insight into the fate of cardiomyocytes in ischemia-reperfusion injury: from iron metabolism to ferroptosis. Front Cell Dev Biol. 2021;9:799499.","journal-title":"Front Cell Dev Biol"},{"key":"1350_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105466","volume":"166","author":"N Li","year":"2021","unstructured":"Li N, Jiang W, Wang W, Xiong R, Wu X, Geng Q. Ferroptosis and its emerging roles in cardiovascular diseases. Pharm Res. 2021;166:105466.","journal-title":"Pharm Res"},{"key":"1350_CR92","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jacbts.2022.03.012","volume":"7","author":"HD Miyamoto","year":"2022","unstructured":"Miyamoto HD, Ikeda M, Ide T, Tadokoro T, Furusawa S, Abe K, et al. Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl Sci. 2022;7:800\u201319.","journal-title":"JACC Basic Transl Sci"},{"key":"1350_CR93","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11:3052\u20139.","journal-title":"Theranostics"},{"key":"1350_CR94","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab. 2024;35:219\u201334.","journal-title":"Trends Endocrinol Metab"},{"key":"1350_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","volume":"173","author":"X Yang","year":"2022","unstructured":"Yang X, Kawasaki NK, Min J, Matsui T, Wang F. Ferroptosis in heart failure. J Mol Cell Cardiol. 2022;173:141\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"1350_CR96","doi-asserted-by":"publisher","first-page":"53671","DOI":"10.1021\/acsami.1c18061","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ren X, Wang Y, Chen D, Jiang L, Li X, et al. Targeting ferroptosis by polydopamine nanoparticles protects heart against ischemia\/reperfusion injury. ACS Appl Mater Interfaces. 2021;13:53671\u201382.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1350_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.153055","volume":"465","author":"C Dai","year":"2022","unstructured":"Dai C, Kong B, Qin T, Xiao Z, Fang J, Gong Y, et al. Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation. Toxicology. 2022;465:153055.","journal-title":"Toxicology"},{"key":"1350_CR98","doi-asserted-by":"publisher","first-page":"22269","DOI":"10.1073\/pnas.1912700116","volume":"116","author":"A Belavgeni","year":"2019","unstructured":"Belavgeni A, Bornstein SR, von Massenhausen A, Tonnus W, Stumpf J, Meyer C, et al. Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis. Proc Natl Acad Sci USA 2019;116:22269\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1350_CR99","doi-asserted-by":"crossref","unstructured":"Tonnus W, Belavgeni A, Beuschlein F, Eisenhofer G, Fassnacht M, Kroiss M, et al. The role of regulated necrosis in endocrine diseases. Nat. Rev. Endocrinol. 2021;17:497\u2013510.","DOI":"10.1038\/s41574-021-00499-w"},{"key":"1350_CR100","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S2213-8587(23)00154-7","volume":"11","author":"N Perakakis","year":"2023","unstructured":"Perakakis N, Harb H, Hale BG, Varga Z, Steenblock C, Kanczkowski W, et al. Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases. Lancet Diabetes Endocrinol. 2023;11:675\u201393.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1350_CR101","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1055\/a-2190-2803","volume":"56","author":"F Schepp","year":"2024","unstructured":"Schepp F, Schubert U, Schmid J, Lehmann S, Latunde-Dada GO, Kose T, et al. Mechanistic insights into ferroptotic cell death in pancreatic islets. Horm Metab Res. 2024;56:279\u201385.","journal-title":"Horm Metab Res"},{"key":"1350_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23886-3","volume":"12","author":"C Steenblock","year":"2021","unstructured":"Steenblock C, Richter S, Berger I, Barovic M, Schmid J, Schubert U, et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021;12:3534.","journal-title":"Nat Commun"},{"key":"1350_CR103","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/a-2122-5701","volume":"56","author":"QW Zhang","year":"2024","unstructured":"Zhang QW, Wang Y, Tong ZY, Li CP, He LP. Vitamin D may play a vital role in alleviating type 2 diabetes mellitus by modulating the ferroptosis signaling pathway. Horm Metab Res. 2024;56:193\u20136.","journal-title":"Horm Metab Res"},{"key":"1350_CR104","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GRY De Meyer","year":"2024","unstructured":"De Meyer GRY, Zurek M, Puylaert P, Martinet W. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat Rev Cardiol. 2024;21:312\u201325.","journal-title":"Nat Rev Cardiol"},{"key":"1350_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215612","volume":"14","author":"JG Neels","year":"2023","unstructured":"Neels JG, Gollentz C, Chinetti G. Macrophage death in atherosclerosis: potential role in calcification. Front Immunol. 2023;14:1215612.","journal-title":"Front Immunol"},{"key":"1350_CR106","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-021-04054-3","volume":"12","author":"S Ouyang","year":"2021","unstructured":"Ouyang S, You J, Zhi C, Li P, Lin X, Tan X, et al. Ferroptosis: the potential value target in atherosclerosis. Cell Death Dis. 2021;12:782.","journal-title":"Cell Death Dis"},{"key":"1350_CR107","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41420-023-01748-9","volume":"9","author":"B Yan","year":"2023","unstructured":"Yan B, Belke D, Gui Y, Chen YX, Jiang ZS, Zheng XL. Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells. Cell Death Discov. 2023;9:456.","journal-title":"Cell Death Discov"},{"key":"1350_CR108","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Li W, Leng Y, Xiong Y, Xia Z. Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol. 2020;39:210\u201325.","journal-title":"DNA Cell Biol"},{"key":"1350_CR109","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/01.CIR.89.3.969","volume":"89","author":"A Ascherio","year":"1994","unstructured":"Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation. 1994;89:969\u201374.","journal-title":"Circulation"},{"key":"1350_CR110","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/oxfordjournals.aje.a117060","volume":"139","author":"Y Liao","year":"1994","unstructured":"Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol. 1994;139:704\u201312.","journal-title":"Am J Epidemiol"},{"key":"1350_CR111","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehi027","volume":"26","author":"AD van der","year":"2005","unstructured":"van der AD, Peeters PH, Grobbee DE, Marx JJ, van der Schouw YT. Dietary haem iron and coronary heart disease in women. Eur Heart J. 2005;26:257\u201362.","journal-title":"Eur Heart J"},{"key":"1350_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20:7\u201323.","journal-title":"Nat Rev Cardiol"},{"key":"1350_CR113","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","volume":"104","author":"E Ku","year":"2023","unstructured":"Ku E, Del Vecchio L, Eckardt KU, Haase VH, Johansen KL, Nangaku M, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104:655\u201380.","journal-title":"Kidney Int"},{"key":"1350_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117389","volume":"387","author":"J Deng","year":"2023","unstructured":"Deng J, Tang X, Tang R, Chen J, Guo H, Zhou Q, et al. Atherogenic index predicts all-cause and cardiovascular mortality in incident peritoneal dialysis patients. Atherosclerosis. 2023;387:117389.","journal-title":"Atherosclerosis"},{"key":"1350_CR115","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","volume":"373","author":"HJL Heerspink","year":"2009","unstructured":"Heerspink HJL, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ. et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009;373:1009\u201315.","journal-title":"Lancet"},{"key":"1350_CR116","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/sdi.12527","volume":"29","author":"BG Stegmayr","year":"2016","unstructured":"Stegmayr BG. Sources of mortality on dialysis with an emphasis on microemboli. Semin Dial. 2016;29:442\u20136.","journal-title":"Semin Dial"},{"key":"1350_CR117","doi-asserted-by":"crossref","unstructured":"Maremonti F, Meyer C, Linkermann A. Mechanisms and models of kidney tubular necrosis and nephron loss. J Am Soc Nephrol. 2022;33:472\u201386.","DOI":"10.1681\/ASN.2021101293"},{"key":"1350_CR118","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/nu11010168","volume":"11","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in chronic kidney disease. Nutrients. 2019;11:168.","journal-title":"Nutrients"},{"key":"1350_CR119","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.atherosclerosis.2008.07.010","volume":"203","author":"JW Beulens","year":"2009","unstructured":"Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203:489\u201393.","journal-title":"Atherosclerosis"},{"key":"1350_CR120","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/jn\/134.11.3100","volume":"134","author":"JM Geleijnse","year":"2004","unstructured":"Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134:3100\u20135.","journal-title":"J Nutr"},{"key":"1350_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103005","volume":"5","author":"A Belavgeni","year":"2024","unstructured":"Belavgeni A, Maremonti F, Linkermann A. Protocol for isolating murine kidney tubules and ex vivo cell death assays. STAR Protoc. 2024;5:103005.","journal-title":"STAR Protoc"},{"key":"1350_CR122","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.chembiol.2020.03.016","volume":"27","author":"A Belavgeni","year":"2020","unstructured":"Belavgeni A, Meyer C, Stumpf J, Hugo C, Linkermann A. Ferroptosis and necroptosis in the kidney. Cell Chem Biol. 2020;27:448\u201362.","journal-title":"Cell Chem Biol"},{"key":"1350_CR123","doi-asserted-by":"crossref","unstructured":"Amaral EP, Costa DL, Namasivayam S, Riteau N, Kamenyeva O, Mittereder L, et al. A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis. J Exp Med. 2019;216:556\u201370.","DOI":"10.1084\/jem.20181776"},{"key":"1350_CR124","doi-asserted-by":"publisher","first-page":"e20220504","DOI":"10.1084\/jem.20220504","volume":"219","author":"EP Amaral","year":"2022","unstructured":"Amaral EP, Foreman TW, Namasivayam S, Hilligan KL, Kauffman KD, Barbosa Bomfim CC, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219:e20220504.","journal-title":"J Exp Med"},{"key":"1350_CR125","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41564-023-01523-7","volume":"9","author":"EP Amaral","year":"2024","unstructured":"Amaral EP, Namasivayam S, Queiroz ATL, Fukutani E, Hilligan KL, Aberman K, et al. BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility. Nat Microbiol. 2024;9:120\u201335.","journal-title":"Nat Microbiol"},{"key":"1350_CR126","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","volume":"14","author":"S Masaldan","year":"2018","unstructured":"Masaldan S, Clatworthy SAS, Gamell C, Meggyesy PM, Rigopoulos AT, Haupt S, et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol. 2018;14:100\u201315.","journal-title":"Redox Biol"},{"key":"1350_CR127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1074\/jbc.RA119.009548","volume":"295","author":"H Nishizawa","year":"2020","unstructured":"Nishizawa H, Matsumoto M, Shindo T, Saigusa D, Kato H, Suzuki K, et al. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J Biol Chem. 2020;295:69\u201382.","journal-title":"J Biol Chem"},{"key":"1350_CR128","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00018-016-2201-6","volume":"73","author":"JM Weinberg","year":"2016","unstructured":"Weinberg JM, Bienholz A, Venkatachalam MA. The role of glycine in regulated cell death. Cell Mol Life Sci. 2016;73:2285\u2013308.","journal-title":"Cell Mol Life Sci"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01350-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T17:02:46Z","timestamp":1725296566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":128,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1038\/s41418-024-01350-1","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"12 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}